| pubmed-article:2810081 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2810081 | lifeskim:mentions | umls-concept:C0015392 | lld:lifeskim |
| pubmed-article:2810081 | lifeskim:mentions | umls-concept:C0026447 | lld:lifeskim |
| pubmed-article:2810081 | lifeskim:mentions | umls-concept:C0023311 | lld:lifeskim |
| pubmed-article:2810081 | lifeskim:mentions | umls-concept:C0019134 | lld:lifeskim |
| pubmed-article:2810081 | lifeskim:mentions | umls-concept:C0023319 | lld:lifeskim |
| pubmed-article:2810081 | lifeskim:mentions | umls-concept:C0205148 | lld:lifeskim |
| pubmed-article:2810081 | lifeskim:mentions | umls-concept:C0205349 | lld:lifeskim |
| pubmed-article:2810081 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:2810081 | pubmed:dateCreated | 1989-12-21 | lld:pubmed |
| pubmed-article:2810081 | pubmed:abstractText | The biocompatibility of heparin surface modified poly(methyl methacrylate) intraocular lenses (IOLs) was evaluated in two experiments following implantation in the anterior and posterior eye chambers of adult cynomolgus monkeys. Throughout the study, large inflammatory cells and prominent pigment deposits were seen on the unmodified lenses, whereas the heparin surface modified IOLs remained almost free of precipitates. Similarly, fewer posterior synechias were observed in eyes implanted with surface modified IOLs in the posterior chamber than in eyes implanted with control lenses. Histopathological examination of enucleated eyes confirmed the clinical findings. These experiments strongly support the idea that surface modification with heparin is a useful way to reduce clinical complications following cataract surgery with IOL implantation. | lld:pubmed |
| pubmed-article:2810081 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2810081 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2810081 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2810081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2810081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2810081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2810081 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2810081 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2810081 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:2810081 | pubmed:issn | 0886-3350 | lld:pubmed |
| pubmed-article:2810081 | pubmed:author | pubmed-author:PhilipsonBB | lld:pubmed |
| pubmed-article:2810081 | pubmed:author | pubmed-author:LarssonRR | lld:pubmed |
| pubmed-article:2810081 | pubmed:author | pubmed-author:FagerholmPP | lld:pubmed |
| pubmed-article:2810081 | pubmed:author | pubmed-author:SelénGG | lld:pubmed |
| pubmed-article:2810081 | pubmed:author | pubmed-author:LydahlEE | lld:pubmed |
| pubmed-article:2810081 | pubmed:author | pubmed-author:HolmbergAA | lld:pubmed |
| pubmed-article:2810081 | pubmed:author | pubmed-author:BjörklundHH | lld:pubmed |
| pubmed-article:2810081 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2810081 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:2810081 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2810081 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2810081 | pubmed:pagination | 485-90 | lld:pubmed |
| pubmed-article:2810081 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:2810081 | pubmed:meshHeading | pubmed-meshheading:2810081-... | lld:pubmed |
| pubmed-article:2810081 | pubmed:meshHeading | pubmed-meshheading:2810081-... | lld:pubmed |
| pubmed-article:2810081 | pubmed:meshHeading | pubmed-meshheading:2810081-... | lld:pubmed |
| pubmed-article:2810081 | pubmed:meshHeading | pubmed-meshheading:2810081-... | lld:pubmed |
| pubmed-article:2810081 | pubmed:meshHeading | pubmed-meshheading:2810081-... | lld:pubmed |
| pubmed-article:2810081 | pubmed:meshHeading | pubmed-meshheading:2810081-... | lld:pubmed |
| pubmed-article:2810081 | pubmed:meshHeading | pubmed-meshheading:2810081-... | lld:pubmed |
| pubmed-article:2810081 | pubmed:meshHeading | pubmed-meshheading:2810081-... | lld:pubmed |
| pubmed-article:2810081 | pubmed:meshHeading | pubmed-meshheading:2810081-... | lld:pubmed |
| pubmed-article:2810081 | pubmed:meshHeading | pubmed-meshheading:2810081-... | lld:pubmed |
| pubmed-article:2810081 | pubmed:meshHeading | pubmed-meshheading:2810081-... | lld:pubmed |
| pubmed-article:2810081 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2810081 | pubmed:articleTitle | Heparin surface modified intraocular lenses implanted in the monkey eye. | lld:pubmed |
| pubmed-article:2810081 | pubmed:affiliation | Department of Ophthalmology, Karolinska Institute, Stockholm, Sweden. | lld:pubmed |
| pubmed-article:2810081 | pubmed:publicationType | Journal Article | lld:pubmed |
